These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


563 related items for PubMed ID: 18536450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 3. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY, Hsu CH, Sheu MT.
    J Pharm Biomed Anal; 2010 Nov 02; 53(3):799-803. PubMed ID: 20619996
    [Abstract] [Full Text] [Related]

  • 4. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP, Kulkarni V, Murahari M, Nayak UY, Bhat P, Suvarna V, Dravyakar B.
    Mol Pharm; 2017 Apr 03; 14(4):1231-1242. PubMed ID: 28248111
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B, Zhong S, Li N, Li X, Yi J, Jin M.
    Drug Dev Ind Pharm; 2013 Nov 03; 39(11):1638-43. PubMed ID: 24087855
    [Abstract] [Full Text] [Related]

  • 8. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM, Mishra B.
    AAPS PharmSciTech; 2016 Apr 03; 17(2):272-83. PubMed ID: 26077622
    [Abstract] [Full Text] [Related]

  • 9. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R.
    Pharm Dev Technol; 2013 Apr 03; 18(2):313-22. PubMed ID: 21699389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO, Mahaguna V, Sriwongjanya M.
    Eur J Pharm Biopharm; 1998 Nov 03; 46(3):355-60. PubMed ID: 9885309
    [Abstract] [Full Text] [Related]

  • 12. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L, Zhang H, Song W, Gu D, Hu Q.
    Carbohydr Polym; 2012 Nov 06; 90(4):1719-24. PubMed ID: 22944438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of beta-cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets.
    Shivakumar HN, Desai BG, Pandya S, Karki SS.
    PDA J Pharm Sci Technol; 2007 Nov 06; 61(6):472-91. PubMed ID: 18410048
    [Abstract] [Full Text] [Related]

  • 15. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
    Zhang XN, Yan XY, Tang LH, Gong JH, Zhang Q.
    Yao Xue Xue Bao; 2005 Apr 06; 40(4):369-72. PubMed ID: 16011270
    [Abstract] [Full Text] [Related]

  • 16. Preparation of natural borneol/2-hydroxypropyl-β-cyclodextrin inclusion complex and its effect on the absorption of tetramethylpyrazine phosphate in mouse.
    Su J, Chen J, Li L, Li B, Shi L, Zhang H, Ding X.
    Chem Pharm Bull (Tokyo); 2012 Apr 06; 60(6):736-42. PubMed ID: 22689424
    [Abstract] [Full Text] [Related]

  • 17. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.
    Lu Y, Guo T, Qi J, Zhang J, Wu W.
    AAPS PharmSciTech; 2012 Dec 06; 13(4):1222-9. PubMed ID: 22968546
    [Abstract] [Full Text] [Related]

  • 18. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J, Jiang Q, Deng P, Chen Q, Yu M, Shang J, Li W.
    J Pharm Pharmacol; 2017 Jun 06; 69(6):663-674. PubMed ID: 28299800
    [Abstract] [Full Text] [Related]

  • 19. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
    Alonso EC, Riccomini K, Silva LA, Galter D, Lima EM, Durig T, Taveira SF, Martins FT, Cunha-Filho MS, Marreto RN.
    J Pharm Pharmacol; 2016 Oct 06; 68(10):1299-309. PubMed ID: 27465985
    [Abstract] [Full Text] [Related]

  • 20. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L, Garnero C, Chattah AK, Delvadia P, Karnes T, Longhi MR, Salgado HR.
    AAPS PharmSciTech; 2015 Jun 06; 16(3):683-91. PubMed ID: 25511811
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.